Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M39,081Revenue $M10,235Net Margin (%)16.6Z-Score3.3
Enterprise Value $M42,826EPS $3.6Operating Margin %20.8F-Score6
P/E(ttm))26.2Cash Flow Per Share $5.3Pre-tax Margin (%)19.8Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %6.6Quick Ratio1.3Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %6.1Current Ratio1.8Lower Leverage y-yY
Price/Cash Flow11.0y-y EBITDA Growth Rate %-4.8ROA % (ttm)8.5Higher Current Ratio y-yN
Dividend Yield %1.5Insider Buy (3m)0ROE % (ttm)18.4Less Shares Outstanding y-yY
Payout Ratio %37.0Shares Outstanding M451ROI % (ttm)10.6Gross Margin Increase y-yN

Gurus Latest Trades with COV

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
COVYacktman Focused Fund 2014-06-30 Sold Out -0.62%$69.03 - $91.24
($74.56)
$ 86.5116%Sold Out0
COVYacktman Fund 2014-06-30 Sold Out -0.56%$69.03 - $91.24
($74.56)
$ 86.5116%Sold Out0
COVJoel Greenblatt 2014-03-31 Buy $66.35 - $72.5
($69.62)
$ 86.5124%New holding, 3746 sh.3,746
COVRay Dalio 2014-03-31 Reduce-0.02%$66.35 - $72.5
($69.62)
$ 86.5124%Reduce -41.8%47,058
COVVanguard Health Care Fund 2013-12-31 Add0.22%$59.82 - $68.42
($65.08)
$ 86.5133%Add 24.79%4,994,700
COVRay Dalio 2013-12-31 Buy 0.04%$59.82 - $68.42
($65.08)
$ 86.5133%New holding, 80858 sh.80,858
COVJohn Keeley 2013-12-31 Reduce-0.06%$59.82 - $68.42
($65.08)
$ 86.5133%Reduce -52.66%44,520
COVJoel Greenblatt 2013-12-31 Sold Out -0.03%$59.82 - $68.42
($65.08)
$ 86.5133%Sold Out0
COVJoel Greenblatt 2013-09-30 Reduce-0.08%$57.12 - $63.8
($61.08)
$ 86.5142%Reduce -64.08%16,584
COVVanguard Health Care Fund 2013-06-30 Add0.37%$50.69 - $56.84
($54.09)
$ 86.5160%Add 66.94%4,002,600
COVJoel Greenblatt 2013-06-30 Buy 0.12%$50.69 - $56.84
($54.09)
$ 86.5160%New holding, 46170 sh.46,170
COVRonald Muhlenkamp 2013-06-30 Reduce-2.78%$50.69 - $56.84
($54.09)
$ 86.5160%Reduce -53.5%174,170
COVJean-Marie Eveillard 2013-06-30 Reduce-0.16%$50.69 - $56.84
($54.09)
$ 86.5160%Reduce -99.79%1,500
COVLeon Cooperman 2013-06-30 Sold Out -0.04%$50.69 - $56.84
($54.09)
$ 86.5160%Sold Out0
COVRay Dalio 2013-06-30 Sold Out -0.04%$50.69 - $56.84
($54.09)
$ 86.5160%Sold Out0
COVLeon Cooperman 2013-03-31 Buy 0.93%$52.59 - $61.79
($57.3)
$ 86.5151%New holding, 887300 sh.887,300
COVJean-Marie Eveillard 2013-03-31 Reduce-0.06%$52.59 - $61.79
($57.3)
$ 86.5151%Reduce -30.95%700,891
COVRay Dalio 2013-03-31 Reduce-0.01%$52.59 - $61.79
($57.3)
$ 86.5151%Reduce -22.49%60,996
COVRay Dalio 2012-12-31 Buy 0.05%$48.6 - $55.05
($52.01)
$ 86.5166%New holding, 78696 sh.78,696
COVJean-Marie Eveillard 2012-12-31 Reduce-0.06%$48.6 - $55.05
($52.01)
$ 86.5166%Reduce -21.14%1,014,988
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

COV is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
COV Vanguard Health Care Fund 2014-06-304,994,7001.111.2
COV Yacktman Focused Fund 2014-06-30000Sold Out
COV Yacktman Fund 2014-06-30000Sold Out
COV Joel Greenblatt 2014-03-313,74600New Buy
COV Jean-Marie Eveillard 2014-03-311,50000
COV Ronald Muhlenkamp 2014-03-31181,4550.042.4-0.1%
COV Donald Yacktman 2014-03-311,784,8250.40.55-0.31%
COV John Keeley 2014-03-3143,7700.010.06-1.68%
COV Dodge & Cox 2014-03-31101,5170.020.01-8.8%
COV Mario Gabelli 2014-03-31543,5600.120.22-12.63%
COV Ray Dalio 2014-03-3147,0580.010.03-41.8%
Premium Most recent portfolio changes are included for Premium Members only!


COV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ALMEIDA JOSE EPresident and Chief Executive 2014-06-16Sell51,166$92.05-5.27view
King Brian DouglasVice President 2014-04-29Sell15,569$70.1124.38view
Dockendorff Charles JEVP & CFO 2014-03-28Sell90,730$72.520.28view
ALMEIDA JOSE EPresident and Chief Executive 2014-02-28Sell50,000$7221.11view
Lannum Coleman N IIIVice President 2014-02-18Sell3,200$71.422.13view
BROWN RICHARD G JRVice President and Controller 2014-02-13Sell4,000$7122.82view
Lannum Coleman N IIIVice President 2014-02-12Sell961$70.2224.18view
Wehrly Peter LSenior Vice President 2014-02-11Sell8,286$69.9724.62view
Hanson Bryan CSenior Vice President 2014-02-11Sell32,480$69.9724.62view
King Brian DouglasVice President 2014-02-11Sell17,946$7024.57view

Press Releases about COV :

    Quarterly/Annual Reports about COV:

    News about COV:

    Articles On GuruFocus.com
    The Gabelli Equity Income Fund Second Quarter 2014 Shareholder Commentary Jul 25 2014 
    Steven Romick's Top Five Stocks Jul 11 2014 
    American Water Works - Nice Steady Upward Jun 21 2014 
    Major British Companies Lead Top Guru-Held UK and Ireland Stocks Jun 10 2014 
    4 Top Stocks in the Medical Device Sector Apr 11 2014 
    Weekly Insider Sells Highlight: CUK, CBI, COV, DWRE Mar 30 2014 
    Weekly CFO Sells Highlight: Chicago Bridge and Iron Company, Covidien PLC, Carnival PLC, Google Inc. Mar 30 2014 
    We Are Confident About Baxter's Plan to Create Two Separate Health Care Companies Mar 28 2014 
    Can Malllinckrodt Keep on Crushing Expectations? Mar 19 2014 
    Weekly 52-Week Highs Highlight: COV, EQT, XLNX, TEVA Mar 03 2014 

    More From Our Partners
    Tax Inversion Puts These 3 Mutual Funds in Focus - Best of Funds Jul 30 2014 - ZACKS

    More From Other Websites
    COVIDIEN PLC Files SEC form 10-Q, Quarterly Report Jul 30 2014
    Analysis - Ireland has too much to lose to deter U.S. companies re-homing Jul 30 2014
    invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors Jul 30 2014
    [video] Merck CEO to CNBC: US tax system broken Jul 29 2014
    Covidien Beats on Q3 Earnings but Revenues Miss Jul 25 2014
    MARK CUBAN: If Your Company Is Moving For Tax Reasons, I'm Selling Your Stock Jul 25 2014
    Covidien PLC Earnings Call scheduled for 8:30 am ET today Jul 25 2014
    Obama Goes On The Attack Against Companies Doing Inversions To Move To Countries Where They Pay Less... Jul 25 2014
    Q3 2014 Covidien plc Earnings Release - Before Market Open Jul 25 2014
    Obama calls on Congress to end inversion deals, NY Times reports Jul 25 2014
    Covidien reports Q3 Surgical Solutions sales up 8% to $1.31B Jul 25 2014
    COVIDIEN PLC Files SEC form 8-K, Results of Operations and Financial Condition Jul 25 2014
    Covidien Reports Third-Quarter Fiscal 2014 Results Jul 25 2014
    Covidien Expands Internship Program, And With It, Engineering Hiring Pipeline Jul 24 2014
    Covidien Earnings Preview: Has Merger News Shaken Expectations? Jul 24 2014
    Why Covidien Stock Is Still Undervalued Despite the Medtronic Deal Jul 24 2014
    COVIDIEN PLC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Jul 22 2014
    Covidien Announces Leadership Appointment Jul 22 2014
    [video] Covidien, Williams Companies Offer Dynamic Dividend Plays Jul 21 2014
    Tax inversions allow firms to avoid state taxes Jul 21 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide